Literature DB >> 7816080

Drug malabsorption and resistant tuberculosis in HIV-infected patients.

K B Patel, R Belmonte, H M Crowe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7816080     DOI： 10.1056/NEJM199502023320518

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  34 in total

1.  Malabsorption of antimycobacterial drugs as a cause of treatment failure in tuberculosis.

Authors:  João Bento; Raquel Duarte; Maria Céu Brito; Sónia Leite; Maria Rosário Lobato; Maria do Carmo Caldeira; Aurora Carvalho
Journal:  BMJ Case Rep       Date:  2010-09-29

Review 2.  Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.

Authors:  W J Burman; K Gallicano; C Peloquin
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

3.  Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption.

Authors:  Justin J Wilkins; Radojka M Savic; Mats O Karlsson; Grant Langdon; Helen McIlleron; Goonaseelan Pillai; Peter J Smith; Ulrika S H Simonsson
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

4.  Oral bioavailability and pharmacokinetics of ciprofloxacin in patients with AIDS.

Authors:  R C Owens; K B Patel; M A Banevicius; R Quintiliani; C H Nightingale; D P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 5.  Review of evidence for measuring drug concentrations of first-line antitubercular agents in adults.

Authors:  Kyle John Wilby; Mary H H Ensom; Fawziah Marra
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

6.  Pharmacokinetics of the First-Line Antituberculosis Drugs in Ghanaian Children with Tuberculosis with or without HIV Coinfection.

Authors:  Sampson Antwi; Hongmei Yang; Anthony Enimil; Anima M Sarfo; Fizza S Gillani; Daniel Ansong; Albert Dompreh; Antoinette Orstin; Theresa Opoku; Dennis Bosomtwe; Lubbe Wiesner; Jennifer Norman; Charles A Peloquin; Awewura Kwara
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 7.  Transmission of drug-resistant tuberculosis in HIV-endemic settings.

Authors:  Palwasha Y Khan; Tom A Yates; Muhammad Osman; Robin M Warren; Yuri van der Heijden; Nesri Padayatchi; Edward A Nardell; David Moore; Barun Mathema; Neel Gandhi; Vegard Eldholm; Keertan Dheda; Anneke C Hesseling; Valerie Mizrahi; Roxana Rustomjee; Alexander Pym
Journal:  Lancet Infect Dis       Date:  2018-12-13       Impact factor: 25.071

8.  Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS.

Authors:  M K Lacy; D P Nicolau; C H Nightingale; A Geffken; R Teng; J Vincent; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

9.  Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients.

Authors:  Helen McIlleron; Peter Wash; André Burger; Jennifer Norman; Peter I Folb; Pete Smith
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

10.  Mortality among patients with tuberculosis requiring intensive care: a retrospective cohort study.

Authors:  Denise R Silva; Diego M Menegotto; Luis F Schulz; Marcelo B Gazzana; Paulo Tr Dalcin
Journal:  BMC Infect Dis       Date:  2010-03-07       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.